Bioscavenging of organophosphate (OP) by human proteins is emerging as a promising medical intervention for prophylaxis and post-exposure treatment against chemical warfare nerve agents. The best-.studied bioscavengers (BSCs) to date, meeting considerable success in pre-clinical research, are human cholinesterases (ChEs). However, ChEs, which are highly efficient in binding and sequestering OPs, are also inactivated by the toxins and therefore administration of large amounts of protein is necessary for full protection, raising the question of the practicality of this approach. The development of improved biocatalysts (BCT) (paraoxonase 1) that can catalytically degrade OPs may address this concern. The proposed effort offers a novel means to biomanufacture recombinant BSCs and BCTs based on the human proteins, butyrylcholinesterase and paraoxonase 1. In collaboration with the other projects participating in the Center, the capacity of these proteins to sequester or hydrolyze OPs will be improved by subjecting their genes to either random in vitro evolution or rational mutagenesis. To that end, we will undertake high-throughput screening of mutant enzyme libraries, in particular to improve the stability and drug-like properties of paraoxonase I. In addition, post-translational glycosylation systems or protein PEGylation procedures will be developed to increase the circulating lifetimes and to eliminate potential antigenicity of proteins produced in non-human, recombinant organisms. The OSU team (Project 6) will utilize the transgenic microalgae, Chlamydomonas reinhardtii, to produce pilot-plant scale quantities of these products for direct recovery from the culture media. In addition, they will optimize this production system for scale-up to commercial production capacity. The primary significance of this project is that it will develop pilot-plant systems for the production of enhanced, second-generation, improved ChE-based BSC and BCT products suitable for human clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
5U54NS058183-05
Application #
8117146
Study Section
Special Emphasis Panel (ZNS1)
Project Start
Project End
Budget Start
2010-06-01
Budget End
2011-09-29
Support Year
5
Fiscal Year
2010
Total Cost
$428,845
Indirect Cost
Name
U.S. Army Medical Research Institute Chem Def
Department
Type
DUNS #
168812329
City
Aberdeen Proving Ground
State
MD
Country
United States
Zip Code
21010
Ashani, Yacov; Leader, Haim; Aggarwal, Nidhi et al. (2016) In vitro evaluation of the catalytic activity of paraoxonases and phosphotriesterases predicts the enzyme circulatory levels required for in vivo protection against organophosphate intoxications. Chem Biol Interact 259:252-256
Smith, Carl D; Wright, Linnzi K M; Garcia, Gregory E et al. (2015) Hormone-dependence of sarin lethality in rats: Sex differences and stage of the estrous cycle. Toxicol Appl Pharmacol 287:253-7
Ben-David, Moshe; Sussman, Joel L; Maxwell, Christopher I et al. (2015) Catalytic stimulation by restrained active-site floppiness--the case of high density lipoprotein-bound serum paraoxonase-1. J Mol Biol 427:1359-1374
Magliery, Thomas J (2015) Protein stability: computation, sequence statistics, and new experimental methods. Curr Opin Struct Biol 33:161-8
Schneider, Jeannine D; Castilho, Alexandra; Neumann, Laura et al. (2014) Expression of human butyrylcholinesterase with an engineered glycosylation profile resembling the plasma-derived orthologue. Biotechnol J 9:501-10
Rockah-Shmuel, Liat; Tawfik, Dan S; Goldsmith, Moshe (2014) Generating targeted libraries by the combinatorial incorporation of synthetic oligonucleotides during gene shuffling (ISOR). Methods Mol Biol 1179:129-37
Dwyer, Mary; Javor, Sacha; Ryan, Daniel A et al. (2014) Novel human butyrylcholinesterase variants: toward organophosphonate detoxication. Biochemistry 53:4476-87
Li, Bin; Duysen, Ellen G; Froment, Marie-Thérèse et al. (2013) Polyclonal antibody to soman-tyrosine. Chem Res Toxicol 26:584-92
Jiang, Wei; Cashman, John R; Nachon, Florian et al. (2013) Mass spectrometry method to identify aging pathways of Sp- and Rp-tabun adducts on human butyrylcholinesterase based on the acid labile P-N bond. Toxicol Sci 132:390-8
Luechapanichkul, Rinrada; Chen, Xianwen; Taha, Hashem A et al. (2013) Specificity profiling of dual specificity phosphatase vaccinia VH1-related (VHR) reveals two distinct substrate binding modes. J Biol Chem 288:6498-510

Showing the most recent 10 out of 48 publications